Agenda – 2017 Trial Protocol Optimization and Design Congress

  • Day One
  • Day Two

Day One

 Monday, July 17, 2017

 PROTOCOL PAIN POINTS

9:00AM – 9:45AM

Review How Protocol Design Is Flawed and Affecting Clinical Research
Richard Murray, Vice President and Deputy Chief Patient Officer, MERCK

9:45AM – 10:30AM

Apply Quality by Design Techniques During Protocol Development to Decrease Complexity and Risk
Sheri Kuss, Director, Clinical Quality Management, PFIZER

10:30AM – 11:00AM

Networking Break

11:00AM – 11:45PM

Discuss the Disconnect Between Protocol Design and the Capabilities of All Stakeholders
Jim Kremidas, Executive Director, ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS

11:45AM – 12:30PM

Accelerate Drug Development through Protocol Harmonization: TransCelerate’s Common Protocol Template
Robert DiCicco, Vice President, Clinical Innovation and Digital Platforms, GSK

12:30PM – 1:30PM

Luncheon

 PARTNERSHIPS IN PATIENT CENTRICITY

1:30PM – 2:15PM

Engage the Patient Perspective in Clinical Trial Protocol Design to Ensure Patient Centricity and Healthy Outcomes
William Smith, M.D., FACC, President, NEW ORLEANS CENTER FOR CLINICAL RESEARCH

2:15PM – 3:00PM

Improve Inclusion and Exclusion Criteria to Safeguard Successful Patient Recruitment and Retention
Kunal Sampat, MNA, Senior Manager, Clinical Programs, ABBOTT VASCULAR

3:00PM – 3:30PM

Networking Break

3:30PM – 4:30PM

PROVIDER PANEL: Gain the Site and Patient Perspective
Jeff Kingsley, Chief Executive Officer, IACT HEALTH
William Smith, M.D., FACC, President, NEW ORLEANS CENTER FOR CLINICAL RESEARCH
Mary Westrick, Adjunct Faculty (Phase I Clinical Trials Specialty), UNIVERSITY OF WISCONSIN, MADISON
Ashish Atreja, Chief Technology Engagement and Innovation Officer, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

4:30PM – 5:15PM

Leverage Patient Insight for Protocol Optimization and Develop Patient-Focused Communications
Madeline Geday, Associate Director, Clinical Research, Global Trial Optimization, MERCK

5:15PM – 6:00PM

Explore the Four Ps Surrounding Patient Centricity
Kate Vila, Manager, Vendor Contract Specialist, BIOVERATIV


Day Two

 Tuesday, July 18, 2017

8:00AM – 8:45AM

Continental Breakfast

 TRIAL PROTOCOL DESIGN AND OPTIMIZATION

9:00AM – 9:45AM

Design Protocols to Embrace Reality: A Phase I Perspective
Mary Westrick, Adjunct Faculty (Phase I Clinical Trials Specialty), UNIVERSITY OF WISCONSIN, MADISON

9:45AM – 10:30AM

Who's Keeping Score? A Quantitative Approach to Trial Feasibility
Luke Stewart, Director of Product Management, SAAMA TECHNOLOGIES

10:30AM – 11:00AM

Networking Break

11:00AM – 11:30AM

Realize the Benefits of Reliable Adherence Data Through the Introduction of Electronic Compliance Monitors Early in Trial Design
Allan Wilson, M.D., Ph.D., President, INFORMATION MEDIARY CORPORATION

12:00PM – 12:30PM

Gauge the Impact of Trial Data Collection and Analysis on the Sponsor and Patients
Patrick Hu, Senior Safety Physician, ASTRAZENECA

12:30PM – 1:30PM

Lunch

 INDUSTRYWIDE SOLUTIONS AND CONSISTENCY

1:30PM – 2:15PM

Write Quality Protocols to Focus on Streamlining, Clarity and Consistency Within the Study Documents
Rosemarie Pincus, Ph.D., Principal Medical Writing Scientist, Oncology Division, JOHNSON & JOHNSON

2:15PM – 2:45PM

Networking Break

2:45PM – 3:30PM

Integrate Wearable Technology with Protocols to Improve Clinical Data Gathering and Patient Centricity
Ashish Atreja, Chief Technology Engagement and Innovation Officer, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

3:30PM – 4:15PM

CASE STUDY: Methods to Enhance Clinical Trial Recruitment
Sarah Berk, Associate Director, Research Partnerships, THE MICHAEL J. FOX FOUNDATION
Bernadette Siddiqi, Research Programs Officer, THE MICHAEL J. FOX FOUNDATION